How is the Avidity Biosciences Inc today?

The Avidity Biosciences Inc today is trading in the green, up by 4.76% at 30.35.

What is Avidity Biosciences Inc Annual Revenue?

Avidity Biosciences Inc Annual Revenue rose 13.99%, in the last year to $10.9 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Avidity Biosciences Inc Annual Net Profit?

Avidity Biosciences Inc Annual Net Profit fell 51.87% in the last year to $322.3 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Avidity Biosciences Inc Price to Earning Ratio?

Avidity Biosciences Inc Price to Earning Ratio is -9.91, which is negative.

What is Avidity Biosciences Inc Stock Price?

Avidity Biosciences Inc Stock Price rose 2.88% and underperformed its sector by 5.98% in the past year.

What is Avidity Biosciences Inc Quarterly Revenue?

Avidity Biosciences Inc Quarterly Revenue fell 55.6% YoY to $1.57 M. Its sector's average revenue growth YoY for the quarter was 3.1%.

What is Avidity Biosciences Inc Quarterly Net profit?

Avidity Biosciences Inc Quarterly Net profit fell 68.14% YoY to $115.77 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Avidity Biosciences Inc Debt to Equity Ratio?

Avidity Biosciences Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Avidity Biosciences Inc Return on Equity(ROE)?

Avidity Biosciences Inc Return on Equity(ROE) for the last financial year was -33.47%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Avidity Biosciences Inc Mutual Fund Holding?

Avidity Biosciences Inc Mutual Fund Holding decreased by 0.32% in the last quarter to 77.93.

What is Avidity Biosciences Inc Institutional Holding?

Avidity Biosciences Inc Institutional Holding increased by 1.35% in the last quarter to 108.95.

Avidity Biosciences Inc XNAS: RNA

Avidity Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Avidity Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Avidity Biosciences Inc
Rating: 1.15100
Author: Trendlyne DVM scores

about

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

30.35 1.38 (4.76%)

45.80% Fall from 52W High

1.3M XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

7.0 / 100

Technically Neutral

39.0 / 100

67

1Yr Price target upside is 120%

14 analysts

Avidity Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Avidity Biosciences Inc FAQ

How is Avidity Biosciences Inc today?

Avidity Biosciences Inc today is trading in the green, and is up by 4.76% at 30.35.

How has Avidity Biosciences Inc performed historically?

Avidity Biosciences Inc is currently trading up 4.76% on an intraday basis. In the past week the stock rose 8.90%. stock has been down -6.07% in the past quarter and rose 2.88% in the past year. You can view this in the overview section.